On September 6, 2023 Precision BioSciences, Inc. (Nasdaq: DTIL), a gene editing company utilizing its proprietary ARCUS platform to develop in vivo gene editing therapies, reported that members of management will participate in the following investor conferences in the month of September (Press release, Precision Biosciences, SEP 6, 2023, View Source [SID1234634948]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Annual Global Investment Conference 2023
Date: September 11, 2023
Time: Available on-demand at 7:00 am ET

Jefferies Gene Editing/Gene Therapy Summit
Date: September 27, 2023
Time: 8:30 am ET

Live webcasts will be accessible on Precision’s website in the Investors section under Events & Presentations at View Source An archived replay will be available for approximately 30 days following the event.